Faculty was Richard Eastell, MD; John Bilezikian, MD; Paul Miller, MD; Sandy Baim,
MD, Meryl LeBoff, MD. Scheduled presentation topics included an update on the development
of new therapeutic agents for the treatment of osteoporosis; management of skeletal
health with aromatase inhibitor therapy; combination therapy with anabolic and
antiresorptive drugs; injectable bisphosphonate therapy; new guidelines for bone
density testing; new guidelines for prevention and treatment of osteoporosis; skeletal
health assessment with technologies other than central DXA; monitoring osteoporosis
therapy; osteoporosis in men; clinical application of bone turnover markers; low
BMD in premenopausal women; and more. Publication from the 2990 bone symposium: Lewiecki EM, Bilezikian JP, Cooper C, Hochberg MC, Luckey MM, Maricic M, Miller PD. Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3-4, 2007. J Clin Densitom. 2008;11(2):313-324.
Get In Touch
We'd love to hear from you. We value your privacy and your time. We will not share your information.